Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment

Metabolism: Clinical and Experimental

Volumn 65, Issue 2, 2016, Pages 124-139

  Barron, Carly C ^a   Bilan, Philip J ^b   Tsakiridis, Theodoros ^c   Tsiani, Evangelia ^a  

^a BROCK UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer metabolism; Glucose transporter; GLUT; SLC2; Warburg effect

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 10; GLUCOSE TRANSPORTER 11; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 13; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUCOSE TRANSPORTER 5; GLUCOSE TRANSPORTER 7; GLUCOSE TRANSPORTER 8; GLUCOSE TRANSPORTER 9; HYPOXIA INDUCIBLE FACTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG; FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER THERAPY; CELL MIGRATION; DRUG TARGETING; GLUCOSE REGULATION SYSTEM; GLUCOSE TRANSPORT; HUMAN; INTRACELLULAR SIGNALING; META ANALYSIS (TOPIC); NEOPLASM; NONHUMAN; ONCOGENE C MYC; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; NEOPLASMS; PHYSIOLOGY; PROGNOSIS;

ANIMALS; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; NEOPLASMS; PROGNOSIS;

EID: 84959463734     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.10.007     Document Type: Review

References (174)

1. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nat Rev Cancer 11 2011 85 95
2. O. Warburg The metabolism of tumors 1930 Constable and Company London
3. M.K. Schwartz Enzymes as prognostic markers and therapeutic indicators in patients with cancer Clin Chim Acta 206 1992 77 82
4. A. Herling, M. Konig, S. Bulik, and H.G. Holzhutter Enzymatic features of the glucose metabolism in tumor cells FEBS J 278 2011 2436 2459
5. S. Dhup, R.K. Dadhich, P.E. Porporato, and P. Sonveaux Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis Curr Pharm Des 18 2012 1319 1330
6. E. Madan, R. Gogna, M. Bhatt, U. Pati, P. Kuppusamy, and A.A. Mahdi Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor Oncotarget 2 2011 948 957
7. R.J. Klement, and U. Kammerer Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) 8 2011 75 [7075-8-75]
8. V.C. Fogg, N.J. Lanning, and J.P. Mackeigan Mitochondria in cancer: at the crossroads of life and death Chin J Cancer 30 2011 526 539
9. R.B. Hamanaka, and N.S. Chandel Targeting glucose metabolism for cancer therapy J Exp Med 209 2012 211 215
10. M. Hatanaka Transport of sugars in tumor cell membranes Biochim Biophys Acta 355 1974 77 104
11. C.C. Riedl, T. Akhurst, S. Larson, S.F. Stanziale, S. Tuorto, A. Bhargava, and et al. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases J Nucl Med 48 2007 771 775
12. G. Calmettes, B. Ribalet, S. John, P. Korge, P. Ping, and J.N. Weiss Hexokinases and cardioprotection J Mol Cell Cardiol 78 2015 107 115
13. S.M. El Sayed, W.G. Mohamed, M.A. Seddik, A.S. Ahmed, A.G. Mahmoud, W.H. Amer, and et al. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study Chin J Cancer 33 2014 356 364
14. J.P. Bayley, and P. Devilee The Warburg effect in 2012 Curr Opin Oncol 24 2012 62 67
15. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 2006 4777 4786
16. K. Adekola, S.T. Rosen, and M. Shanmugam Glucose transporters in cancer metabolism Curr Opin Oncol 24 2012 650 654
17. R. Augustin The protein family of glucose transport facilitators: it's not only about glucose after all IUBMB Life 62 2010 315 333
18. B. Thorens, and M. Mueckler Glucose transporters in the 21st Century Am J Physiol Endocrinol Metab 298 2010 E141 E145
19. M.B. Calvo, A. Figueroa, E.G. Pulido, R.G. Campelo, and L.A. Aparicio Potential role of sugar transporters in cancer and their relationship with anticancer therapy Int J Endocrinol 2010 10.1155/2010/205357 [Epub 2010 Jul 18]
20. H.G. Joost, and B. Thorens The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review) Mol Membr Biol 18 2001 247 256
21. M. Uldry, and B. Thorens The SLC2 family of facilitated hexose and polyol transporters Pflugers Arch 447 2004 480 489
22. F.Q. Zhao, and A.F. Keating Functional properties and genomics of glucose transporters Curr Genomics 8 2007 113 128
23. M. Uldry, M. Ibberson, M. Hosokawa, and B. Thorens GLUT2 is a high affinity glucosamine transporter FEBS Lett 524 2002 199 203
24. K. Takata, T. Kasahara, M. Kasahara, O. Ezaki, and H. Hirano Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers Biochem Biophys Res Commun 173 1990 67 73
25. V. Ganapathy, M. Thangaraju, and P.D. Prasad Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond Pharmacol Ther 121 2009 29 40
26. M.L. Macheda, S. Rogers, and J.D. Best Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer J Cell Physiol 202 2005 654 662
27. A. Godoy, V. Ulloa, F. Rodriguez, K. Reinicke, A.J. Yanez, L. Garcia Mde, and et al. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues J Cell Physiol 207 2006 614 627
28. M. Younes, R.W. Brown, D.R. Mody, L. Fernandez, and R. Laucirica GLUT1 expression in human breast carcinoma: correlation with known prognostic markers Anticancer Res 15 1995 2895 2898
29. S.S. Kang, Y.K. Chun, M.H. Hur, H.K. Lee, Y.J. Kim, S.R. Hong, and et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma Jpn J Cancer Res 93 2002 1123 1128
30. P. Ravazoula, A. Batistatou, C. Aletra, J. Ladopoulos, G. Kourounis, and B. Tzigounis Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes Eur J Gynaecol Oncol 24 2003 544 546
31. P.L. Alo, P. Visca, C. Botti, G.M. Galati, V. Sebastiani, T. Andreano, and et al. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue Am J Clin Pathol 116 2001 129 134
32. R.S. Brown, and R.L. Wahl Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study Cancer 72 1993 2979 2985
33. S.C. Baer, L. Casaubon, and M. Younes Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia J Am Acad Dermatol 37 1997 575 577
34. J.H. Johnson, C.B. Newgard, J.L. Milburn, H.F. Lodish, and B. Thorens The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence J Biol Chem 265 1990 6548 6551
35. C.A. Colville, M.J. Seatter, T.J. Jess, G.W. Gould, and H.M. Thomas Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors Biochem J 290 Pt 3 1993 701 706
36. H. Fukumoto, S. Seino, H. Imura, Y. Seino, R.L. Eddy, Y. Fukushima, and et al. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein Proc Natl Acad Sci U S A 85 1988 5434 5438
37. B. Thorens, Z.Q. Cheng, D. Brown, and H.F. Lodish Liver glucose transporter: a basolateral protein in hepatocytes and intestine and kidney cells Am J Physiol 259 1990 C279 C285
38. M.T. Guillam, P. Dupraz, and B. Thorens Glucose uptake, utilization, and signaling in GLUT2-null islets Diabetes 49 2000 1485 1491
39. T. Yamamoto, Y. Seino, H. Fukumoto, G. Koh, H. Yano, N. Inagaki, and et al. Over-expression of facilitative glucose transporter genes in human cancer Biochem Biophys Res Commun 170 1990 223 230
40. C.H. Wu, Y.S. Ho, C.Y. Tsai, Y.J. Wang, H. Tseng, P.L. Wei, and et al. In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter Int J Cancer 124 2009 2210 2219
41. R. Grobholz, H.J. Hacker, B. Thorens, and P. Bannasch Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis Cancer Res 53 1993 4204 4211
42. J. Levi, Z. Cheng, O. Gheysens, M. Patel, C.T. Chan, Y. Wang, and et al. Fluorescent fructose derivatives for imaging breast cancer cells Bioconjug Chem 18 2007 628 634
43. H. Liu, D. Huang, D.L. McArthur, L.G. Boros, N. Nissen, and A.P. Heaney Fructose induces transketolase flux to promote pancreatic cancer growth Cancer Res 70 2010 6368 6376
44. T. Tomita Immunocytochemical localization of glucose transporter-2 (GLUT-2) in pancreatic islets and islet cell tumors Endocr Pathol 10 1999 213 221
45. Y. Seino, T. Yamamoto, K. Inoue, M. Imamura, S. Kadowaki, H. Kojima, and et al. Abnormal facilitative glucose transporter gene expression in human islet cell tumors J Clin Endocrinol Metab 76 1993 75 78
46. D. Knaack, D.M. Fiore, M. Surana, M. Leiser, M. Laurance, D. Fusco-DeMane, and et al. Clonal insulinoma cell line that stably maintains correct glucose responsiveness Diabetes 43 1994 1413 1417
47. Y. Noguchi, D. Marat, A. Saito, T. Yoshikawa, C. Doi, K. Fukuzawa, and et al. Expression of facilitative glucose transporters in gastric tumors Hepatogastroenterology 46 1999 2683 2689
48. R.S. Haber, S.P. Weinstein, E. O'Boyle, and S. Morgello Tissue distribution of the human GLUT3 glucose transporter Endocrinology 132 1993 2538 2543
49. E. Maratou, G. Dimitriadis, A. Kollias, E. Boutati, V. Lambadiari, P. Mitrou, and et al. Glucose transporter expression on the plasma membrane of resting and activated white blood cells Eur J Clin Invest 37 2007 282 290
50. M. Younes, R.W. Brown, M. Stephenson, M. Gondo, and P.T. Cagle Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival Cancer 80 1997 1046 1051
51. N. Suzawa, M. Ito, S. Qiao, K. Uchida, M. Takao, T. Yamada, and et al. Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size Lung Cancer 72 2011 191 198
52. T. Kurata, T. Oguri, T. Isobe, S. Ishioka, and M. Yamakido Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases Jpn J Cancer Res 90 1999 1238 1243
53. L.F. de Geus-Oei, J.H. van Krieken, R.P. Aliredjo, P.F. Krabbe, C. Frielink, A.F. Verhagen, and et al. Biological correlates of FDG uptake in non-small cell lung cancer Lung Cancer 55 2007 79 87
54. M. Younes, L.V. Lechago, J.R. Somoano, M. Mosharaf, and J. Lechago Immunohistochemical detection of Glut3 in human tumors and normal tissues Anticancer Res 17 1997 2747 2750
55. A. Krzeslak, K. Wojcik-Krowiranda, E. Forma, P. Jozwiak, H. Romanowicz, A. Bienkiewicz, and et al. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers Pathol Oncol Res 18 2012 721 728
56. R.J. Boado, K.L. Black, and W.M. Pardridge Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors Brain Res Mol Brain Res 27 1994 51 57
57. S. Nagamatsu, H. Sawa, A. Wakizaka, and T. Hoshino Expression of facilitative glucose transporter isoforms in human brain tumors J Neurochem 61 1993 2048 2053
58. T. Nishioka, Y. Oda, Y. Seino, T. Yamamoto, N. Inagaki, H. Yano, and et al. Distribution of the glucose transporters in human brain tumors Cancer Res 52 1992 3972 3979
59. V.R. Conde, P.F. Oliveira, A.R. Nunes, C.S. Rocha, E. Ramalhosa, J.A. Pereira, and et al. The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism Exp Cell Res 335 2015 91 98
60. K. Starska, E. Forma, P. Jozwiak, M. Brys, I. Lewy-Trenda, E. Brzezinska-Blaszczyk, and et al. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1alpha expression, tumor invasiveness, and patient prognosis Tumour Biol 36 2015 2309 2321
61. C.V. Vaz, R. Marques, M.G. Alves, P.F. Oliveira, J.E. Cavaco, C.J. Maia, and et al. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes J Cancer Res Clin Oncol 2015 10.1007/s00432-015-1992-4
62. P. Mellanen, H. Minn, R. Grenman, and P. Harkonen Expression of glucose transporters in head-and-neck tumors Int J Cancer 56 1994 622 629
63. F.R. Ayala, R.M. Rocha, K.C. Carvalho, A.L. Carvalho, I.W. da Cunha, S.V. Lourenco, and et al. GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma Molecules 15 2010 2374 2387
64. T. Kasahara, and M. Kasahara Characterization of rat Glut4 glucose transporter expressed in the yeast Saccharomyces cerevisiae: comparison with Glut1 glucose transporter Biochim Biophys Acta 1324 1997 111 119
65. S.C. Rumsey, R. Daruwala, H. Al-Hasani, M.J. Zarnowski, I.A. Simpson, and M. Levine Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes J Biol Chem 275 2000 28246 28253
66. C. Binder, L. Binder, D. Marx, A. Schauer, and W. Hiddemann Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues Anticancer Res 17 1997 4299 4304
67. K. Matsuzu, F. Segade, U. Matsuzu, A. Carter, D.W. Bowden, and N.D. Perrier Differential expression of glucose transporters in normal and pathologic thyroid tissue Thyroid 14 2004 806 812
68. T. Higashi, N. Tamaki, T. Honda, T. Torizuka, T. Kimura, T. Inokuma, and et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study J Nucl Med 38 1997 1337 1344
69. S.K. McBrayer, J.C. Cheng, S. Singhal, N.L. Krett, S.T. Rosen, and M. Shanmugam Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy Blood 119 2012 4686 4697
70. X. Wu, and H.H. Freeze GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms Genomics 80 2002 553 557
71. C.F. Burant, J. Takeda, E. Brot-Laroche, G.I. Bell, and N.O. Davidson Fructose transporter in human spermatozoa and small intestine is GLUT5 J Biol Chem 267 1992 14523 14526
72. E.B. Rand, A.M. Depaoli, N.O. Davidson, G.I. Bell, and C.F. Burant Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5 Am J Physiol 264 1993 G1169 G1176
73. G.J. Mantych, D.E. James, and S.U. Devaskar Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier Endocrinology 132 1993 35 40
74. L.C. Cantley Cancer, metabolism, fructose, artificial sweeteners, and going cold turkey on sugar BMC Biology 12 8 2014
75. S.P. Zamora-Leon, D.W. Golde, I.I. Concha, C.I. Rivas, F. Delgado-Lopez, J. Baselga, and et al. Expression of the fructose transporter GLUT5 in human breast cancer Proc Natl Acad Sci U S A 93 1996 1847 1852
76. K.K. Chan, J.Y. Chan, K.K. Chung, and K.P. Fung Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5 J Cell Biochem 93 2004 1134 1142
77. V. Medina Villaamil, G. Aparicio Gallego, L. Valbuena Rubira, R. Garcia Campelo, M. Valladares-Ayerbes, E. Grande Pulido, and et al. Fructose transporter GLUT5 expression in clear renal cell carcinoma Oncol Rep 25 2011 315 323
78. Q. Li, A. Manolescu, M. Ritzel, S. Yao, M. Slugoski, J.D. Young, and et al. Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine Am J Physiol Gastrointest Liver Physiol 287 2004 G236 G242
79. M. Doblado, and K.H. Moley Facilitative glucose transporter 9, a unique hexose and urate transporter Am J Physiol Endocrinol Metab 297 2009 E831 E835
80. R. Augustin, M.O. Carayannopoulos, L.O. Dowd, J.E. Phay, J.F. Moley, and K.H. Moley Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking J Biol Chem 279 2004 16229 16236
81. S.A. Evans, M. Doblado, M.M. Chi, J.A. Corbett, and K.H. Moley Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells Endocrinology 150 2009 5302 5310
82. Y. Itahana, R. Han, S. Barbier, Z. Lei, S. Rozen, and K. Itahana The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense Oncogene 34 2015 1799 1810
83. X. Wu, W. Li, V. Sharma, A. Godzik, and H.H. Freeze Cloning and characterization of glucose transporter 11, a novel sugar transporter that is alternatively spliced in various tissues Mol Genet Metab 76 2002 37 45
84. A.R. Manolescu, R. Augustin, K. Moley, and C. Cheeseman A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity Mol Membr Biol 24 2007 455 463
85. A. Scheepers, S. Schmidt, A. Manolescu, C.I. Cheeseman, A. Bell, C. Zahn, and et al. Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue Mol Membr Biol 22 2005 339 351
86. T. Sasaki, S. Minoshima, A. Shiohama, A. Shintani, A. Shimizu, S. Asakawa, and et al. Molecular cloning of a member of the facilitative glucose transporter gene family GLUT11 (SLC2A11) and identification of transcription variants Biochem Biophys Res Commun 289 2001 1218 1224
87. K. Reinicke, P. Sotomayor, P. Cisterna, C. Delgado, F. Nualart, and A. Godoy Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue J Cell Biochem 113 2012 553 562
88. H. Doege, A. Bocianski, H.G. Joost, and A. Schurmann Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes Biochem J 350 Pt 3 2000 771 776
89. F.L. Byrne, I.K. Poon, S.C. Modesitt, J.L. Tomsig, J.D. Chow, M.E. Healy, and et al. Metabolic vulnerabilities in endometrial cancer Cancer Res 74 2014 5832 5845
90. M. Ibberson, M. Uldry, and B. Thorens GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues J Biol Chem 275 2000 4607 4612
91. O. Gomez, B. Ballester-Lurbe, E. Poch, J.E. Mesonero, and J. Terrado Developmental regulation of glucose transporters GLUT3, GLUT4 and GLUT8 in the mouse cerebellar cortex J Anat 217 2010 616 623
92. N.A. Goldman, E.B. Katz, A.S. Glenn, R.H. Weldon, J.G. Jones, U. Lynch, and et al. GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma Mod Pathol 19 2006 1429 1436
93. P.A. Dawson, J.C. Mychaleckyj, S.C. Fossey, S.J. Mihic, A.L. Craddock, and D.W. Bowden Sequence and functional analysis of GLUT10: a glucose transporter in the type 2 diabetes-linked region of chromosome 20q12-13.1 Mol Genet Metab 74 2001 186 199
94. A.J. McVie-Wylie, D.R. Lamson, and Y.T. Chen Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility Genomics 72 2001 113 117
95. S. Rogers, J.D. Chandler, A.L. Clarke, S. Petrou, and J.D. Best Glucose transporter GLUT12-functional characterization in Xenopus laevis oocytes Biochem Biophys Res Commun 308 2003 422 426
96. S. Rogers, M.L. Macheda, S.E. Docherty, M.D. Carty, M.A. Henderson, W.C. Soeller, and et al. Identification of a novel glucose transporter-like protein-GLUT-12 Am J Physiol Endocrinol Metab 282 2002 E733 E738
97. S. Rogers, S.E. Docherty, J.L. Slavin, M.A. Henderson, and J.D. Best Differential expression of GLUT12 in breast cancer and normal breast tissue Cancer Lett 193 2003 225 233
98. J.D. Chandler, E.D. Williams, J.L. Slavin, J.D. Best, and S. Rogers Expression and localization of GLUT1 and GLUT12 in prostate carcinoma Cancer 97 2003 2035 2042
99. J. Pujol-Gimenez, F.P. de Heredia, M.A. Idoate, R. Airley, M.P. Lostao, and A.R. Evans Could GLUT12 be a potential therapeutic target in cancer treatment? A preliminary report J Cancer 6 2015 139 143
100. F. Stockhammer, A. von Deimling, M. Synowitz, C. Blechschmidt, and F.K. van Landeghem Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II J Mol Histol 39 2008 553 560
101. M. Uldry, M. Ibberson, J.D. Horisberger, J.Y. Chatton, B.M. Riederer, and B. Thorens Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain EMBO J 20 2001 4467 4477
102. M. Uldry, P. Steiner, M.G. Zurich, P. Beguin, H. Hirling, W. Dolci, and et al. Regulated exocytosis of an H +/myo-inositol symporter at synapses and growth cones EMBO J 23 2004 531 540
103. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 2007 1261 1274
104. H. Zaid, C.N. Antonescu, V.K. Randhawa, and A. Klip Insulin action on glucose transporters through molecular switches, tracks and tethers Biochem J 413 2008 201 215
105. P.J. Bilan, T. Ramlal, and A. Klip IGF-I mediated recruitment of glucose transporters from intracellular membranes to plasma membranes in L6 muscle cells Adv Exp Med Biol 293 1991 273 288
106. K.K. Wong, J.A. Engelman, and L.C. Cantley Targeting the PI3K signaling pathway in cancer Curr Opin Genet Dev 20 2010 87 90
107. A. Barthel, S.T. Okino, J. Liao, K. Nakatani, J. Li, J.P. Whitlock Jr., and et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1 J Biol Chem 274 1999 20281 20286
108. J.C. Cheng, S.K. McBrayer, C. Coarfa, S. Dalva-Aydemir, P.H. Gunaratne, J.D. Carpten, and et al. Expression and phosphorylation of the AS160-v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma Cancer Metab 1 2013 14 10.1186/2049-3002-1-14 [3002-1-14]
109. X.L. Cui, A.M. Schlesier, E.L. Fisher, C. Cerqueira, and R.P. Ferraris Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signaling pathway Am J Physiol Gastrointest Liver Physiol 288 2005 G1310 G1320
110. C.A. Stuart, M.E. Howell, Y. Zhang, and D. Yin Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle J Clin Endocrinol Metab 94 2009 3535 3542
111. P.K. Majumder, P.G. Febbo, R. Bikoff, R. Berger, Q. Xue, L.M. McMahon, and et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways Nat Med 10 2004 594 601
112. R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, and C.B. Thompson The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab 7 2008 11 20
113. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
114. M. Obach, A. Navarro-Sabate, J. Caro, X. Kong, J. Duran, M. Gomez, and et al. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia J Biol Chem 279 2004 53562 53570
115. M. Hayashi, M. Sakata, T. Takeda, T. Yamamoto, Y. Okamoto, K. Sawada, and et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells J Endocrinol 183 2004 145 154
116. K. Song, M. Li, X.J. Xu, L. Xuan, G.N. Huang, X.L. Song, and et al. HIF-1alpha and GLUT1 gene expression is associated with chemoresistance of acute myeloid leukemia Asian Pac J Cancer Prev 15 2014 1823 1829
117. S.J. Vannucci, R. Reinhart, F. Maher, C.A. Bondy, W.H. Lee, R.C. Vannucci, and et al. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain Brain Res Dev Brain Res 107 1998 255 264
118. M.U. Baumann, S. Zamudio, and N.P. Illsley Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1 Am J Physiol Cell Physiol 293 2007 C477 C485
119. A.E. Karnoub, and R.A. Weinberg Ras oncogenes: split personalities Nat Rev Mol Cell Biol 9 2008 517 531
120. F. Chiaradonna, E. Sacco, R. Manzoni, M. Giorgio, M. Vanoni, and L. Alberghina Ras-dependent carbon metabolism and transformation in mouse fibroblasts Oncogene 25 2006 5391 5404
121. J. Yun, C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, H. Rajagopalan, and et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells Science 325 2009 1555 1559
122. K. Birsoy, R. Possemato, F.K. Lorbeer, E.C. Bayraktar, P. Thiru, B. Yucel, and et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides Nature 508 2014 108 112
123. D.M. Miller, S.D. Thomas, A. Islam, D. Muench, and K. Sedoris c-Myc and cancer metabolism Clin Cancer Res 18 2012 5546 5553
124. R.C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, and et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc J Biol Chem 275 2000 21797 21800
125. A. Valera, A. Pujol, X. Gregori, E. Riu, J. Visa, and F. Bosch Evidence from transgenic mice that myc regulates hepatic glycolysis FASEB J 9 1995 1067 1078
126. O. Laptenko, and C. Prives Transcriptional regulation by p53: one protein, many possibilities Cell Death Differ 13 2006 951 961
127. F. Schwartzenberg-Bar-Yoseph, M. Armoni, and E. Karnieli The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression Cancer Res 64 2004 2627 2633
128. K. Kawauchi, K. Araki, K. Tobiume, and N. Tanaka p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation Nat Cell Biol 10 2008 611 618
129. J. Zawacka-Pankau, V.V. Grinkevich, S. Hunten, F. Nikulenkov, A. Gluch, H. Li, and et al. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer J Biol Chem 286 2011 41600 41615
130. V. Stambolic, D. MacPherson, D. Sas, Y. Lin, B. Snow, Y. Jang, and et al. Regulation of PTEN transcription by p53 Mol Cell 8 2001 317 325
131. C. Zhang, J. Liu, Y. Liang, R. Wu, Y. Zhao, X. Hong, and et al. Tumour-associated mutant p53 drives the Warburg effect Nat Commun 4 2013 2935
132. J. Gu, H. Yamamoto, H. Fukunaga, K. Danno, I. Takemasa, M. Ikeda, and et al. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer Dig Dis Sci 51 2006 2198 2205
133. T. Berghmans, M. Dusart, M. Paesmans, C. Hossein-Foucher, I. Buvat, C. Castaigne, and et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project J Thorac Oncol 3 2008 6 12
134. L. Pan, P. Gu, G. Huang, H. Xue, and S. Wu Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis Eur J Gastroenterol Hepatol 21 2009 1008 1015
135. T.B. Bartel, J. Haessler, T.L. Brown, J.D. Shaughnessy Jr., F. van Rhee, E. Anaissie, and et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma Blood 114 2009 2068 2076
136. E. Zamagni, F. Patriarca, C. Nanni, B. Zannetti, E. Englaro, A. Pezzi, and et al. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation Blood 118 2011 5989 5995
137. W.W. Ma, H. Jacene, D. Song, F. Vilardell, W.A. Messersmith, D. Laheru, and et al. [18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy J Clin Oncol 27 2009 2697 2704
138. T.C. Yen, L.C. See, C.H. Lai, C.W. Yah-Huei, K.K. Ng, S.Y. Ma, and et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression J Nucl Med 45 2004 22 29
139. T. Kurokawa, Y. Yoshida, K. Kawahara, T. Tsuchida, H. Okazawa, Y. Fujibayashi, and et al. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary Int J Cancer 109 2004 926 932
140. K. Kaira, M. Serizawa, Y. Koh, T. Takahashi, H. Hanaoka, N. Oriuchi, and et al. Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma Eur J Cancer 48 2012 1244 1254
141. S.G. Park, J.H. Lee, W.A. Lee, and K.M. Han Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma Nucl Med Biol 39 2012 1167 1172
142. N. Avril, M. Menzel, J. Dose, M. Schelling, W. Weber, F. Janicke, and et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis J Nucl Med 42 2001 9 16
143. 18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer Eur J Nucl Med Mol Imaging 38 2011 46 52
144. M. Wuest, B.J. Trayner, T.N. Grant, H.S. Jans, J.R. Mercer, D. Murray, and et al. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer Nucl Med Biol 38 2011 461 475
145. F.Y. Chung, M.Y. Huang, C.S. Yeh, H.J. Chang, T.L. Cheng, L.C. Yen, and et al. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients BMC Cancer 9 2009 241 [2407-9-241]
146. J.Y. Sung, G.Y. Kim, S.J. Lim, Y.K. Park, and Y.W. Kim Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract Pathol Res Pract 206 2010 24 29
147. R.S. Haber, A. Rathan, K.R. Weiser, A. Pritsker, S.H. Itzkowitz, C. Bodian, and et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis Cancer 83 1998 34 40
148. G. Cantuaria, A. Fagotti, G. Ferrandina, A. Magalhaes, M. Nadji, R. Angioli, and et al. GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy Cancer 92 2001 1144 1150
149. P.J. Hoskin, A. Sibtain, F.M. Daley, and G.D. Wilson GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON Br J Cancer 89 2003 1290 1297
150. T. Tohma, S. Okazumi, H. Makino, A. Cho, R. Mochizuki, K. Shuto, and et al. Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis Dis Esophagus 18 2005 185 189
151. S. Baer, L. Casaubon, M.R. Schwartz, A. Marcogliese, and M. Younes Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival Laryngoscope 112 2002 393 396
152. S. Yeluri, B. Madhok, K.R. Prasad, P. Quirke, and D.G. Jayne Cancer's craving for sugar: an opportunity for clinical exploitation J Cancer Res Clin Oncol 135 2009 867 877
153. D.G. Hardie, and M.L. Ashford AMPK: regulating energy balance at the cellular and whole body levels Physiology (Bethesda) 29 2014 99 107
154. T. Sanli, A. Rashid, C. Liu, S. Harding, R.G. Bristow, J.C. Cutz, and et al. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells Int J Radiat Oncol Biol Phys 78 2010 221 229
155. Y. Storozhuk, T. Sanli, S.N. Hopmans, C. Schultz, T. Farrell, J.C. Cutz, and et al. Chronic modulation of AMP-kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts Radiat Oncol 7 2012 71
156. Y. Storozhuk, S.N. Hopmans, T. Sanli, C. Barron, E. Tsiani, J.C. Cutz, and et al. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK Br J Cancer 108 2013 2021 2032
157. Thomas Jefferson University Caloric restriction in treating patients with stage 0-I breast cancer undergoing surgery and radiation therapy (CAREFOR) ClinicalTrials.gov [Internet] 2013 National Library of Medicine (US) Bethesda (MD)
158. L.G. Melstrom, M.R. Salabat, X.Z. Ding, B.M. Milam, M. Strouch, J.C. Pelling, and et al. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells Pancreas 37 2008 426 431
159. T.E. Wood, S. Dalili, C.D. Simpson, R. Hurren, X. Mao, F.S. Saiz, and et al. A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death Mol Cancer Ther 7 2008 3546 3555
160. T. Tuccinardi, C. Granchi, J. Iegre, I. Paterni, S. Bertini, M. Macchia, and et al. Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells Bioorg Med Chem Lett 23 2013 6923 6927
161. D. Zhang, Y. Wang, L. Dong, Y. Huang, J. Yuan, W. Ben, and et al. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells Cancer Sci 104 2013 1690 1696
162. Y. Liu, W. Zhang, Y. Cao, Y. Liu, S. Bergmeier, and X. Chen Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms Cancer Lett 298 2010 176 185
163. C.D. Young, A.S. Lewis, M.C. Rudolph, M.D. Ruehle, M.R. Jackman, U.J. Yun, and et al. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo PLoS One 6 2011 e23205 10.1371/journal.pone.0023205
164. S. Rastogi, S. Banerjee, S. Chellappan, and G.R. Simon Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines Cancer Lett 257 2007 244 251
165. Y.D. Wang, S.J. Li, and J.X. Liao Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin Technol Cancer Res Treat 12 2013 525 535
166. X. Fei, M. Qi, B. Wu, Y. Song, Y. Wang, and T. Li MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression FEBS Lett 586 2012 392 397
167. M. Watanabe, N. Abe, Y. Oshikiri, E.J. Stanbridge, and T. Kitagawa Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-kappaB-dependent GLUT3 expression Oncogenesis 1 2012 e21 10.1038/oncsis.2012.21
168. M. Watanabe, H. Naraba, T. Sakyo, and T. Kitagawa DNA damage-induced modulation of GLUT3 expression is mediated through p53-independent extracellular signal-regulated kinase signaling in HeLa cells Mol Cancer Res 8 2010 1547 1557
169. T. Zhan, M. Digel, E.M. Kuch, W. Stremmel, and J. Fullekrug Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins J Cell Biochem 112 2011 849 859
170. T.W. Flaig, M. Glode, D. Gustafson, A. van Bokhoven, Y. Tao, S. Wilson, and et al. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer Prostate 70 2010 848 855
171. A.B. Siegel, R. Narayan, R. Rodriguez, A. Goyal, J.S. Jacobson, K. Kelly, and et al. A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma Integr Cancer Ther 13 2014 46 53
172. F.Q. Zhao, D.R. Glimm, and J.J. Kennelly Distribution of mammalian facilitative glucose transporter messenger RNA in bovine tissues Int J Biochem 25 1993 1897 1903
173. H.S. Hundal, F. Darakhshan, S. Kristiansen, S.J. Blakemore, and E.A. Richter GLUT5 expression and fructose transport in human skeletal muscle Adv Exp Med Biol 441 1998 35 45
174. N. Anzai, K. Ichida, P. Jutabha, T. Kimura, E. Babu, C.J. Jin, and et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans J Biol Chem 283 2008 26834 26838